ASP 8477
Modify Date: 2025-09-05 09:40:43
ASP 8477 structure
|
Common Name | ASP 8477 | ||
|---|---|---|---|---|
| CAS Number | 906737-25-5 | Molecular Weight | 325.368 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C18H19N3O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of ASP 8477A novel potent, highly selective fatty acid amide hydrolase (FAAH) inhibitor with IC50 of 0.99, 1.65 and 57.3 nM for human FAAH-1, FAAH-1 (P129T) and FAAH-2, respectively; displays no appreciable binding affinity to or inhibition against a panel of 65 receptors, ion channels and transporters, including CB1, CB2 receptors and MAGL; elevates AEA concentrations in both plasma and brain in adolescent rats, significantly improves mechanical allodynia and thermal hyperalgesia in capsaicin-induced secondary hyperalgesia model (0.3-3mg/kg, p.o). Pain Phase 2 Discontinued |
| Name | ASP 8477 |
|---|
| Description | A novel potent, highly selective fatty acid amide hydrolase (FAAH) inhibitor with IC50 of 0.99, 1.65 and 57.3 nM for human FAAH-1, FAAH-1 (P129T) and FAAH-2, respectively; displays no appreciable binding affinity to or inhibition against a panel of 65 receptors, ion channels and transporters, including CB1, CB2 receptors and MAGL; elevates AEA concentrations in both plasma and brain in adolescent rats, significantly improves mechanical allodynia and thermal hyperalgesia in capsaicin-induced secondary hyperalgesia model (0.3-3mg/kg, p.o). Pain Phase 2 Discontinued |
|---|---|
| References | References 1. Watabiki T, et al. Eur J Pharmacol. 2017 Nov 15;815:42-48. 2. Bradford D, et al. Pain Med. 2017 Dec 1;18(12):2388-2400. View Related Products by Target FAAH Pain |
| Molecular Formula | C18H19N3O3 |
|---|---|
| Molecular Weight | 325.368 |
| InChIKey | PLCMZPFTMOAGOE-UHFFFAOYSA-N |
| SMILES | O=C(Nc1ccccc1)C1CCN(C(=O)Oc2cccnc2)CC1 |